Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cogstate Ltd ( (AU:CGS) ) has shared an announcement.
Cogstate Ltd has announced the quotation of 399,500 ordinary fully paid securities on the Australian Securities Exchange (ASX), effective from October 17, 2025. This move reflects the company’s ongoing efforts to enhance its capital structure and potentially strengthen its market position, offering stakeholders an opportunity to engage with the company’s growth trajectory.
The most recent analyst rating on (AU:CGS) stock is a Buy with a A$2.00 price target. To see the full list of analyst forecasts on Cogstate Ltd stock, see the AU:CGS Stock Forecast page.
More about Cogstate Ltd
Cogstate Ltd operates in the healthcare industry, specializing in cognitive science and technology. The company provides digital cognitive assessment tools and services, focusing on enhancing brain health and aiding in clinical trials and research.
YTD Price Performance: 136.21%
Average Trading Volume: 183,557
Technical Sentiment Signal: Buy
Current Market Cap: A$417.8M
Find detailed analytics on CGS stock on TipRanks’ Stock Analysis page.